Abstract
Pemphigus is a relatively rare autoimmune bullous disorder involving the skin and mucous epithelia. Clinically characterized by blisters and erosions, its histological hallmark is acantholysis induced by IgG antibodies (ab) against desmoglein 3 and/or desmoglein 1. The role of ab alone in inducing acantholysis is still a matter of debate as several mechanisms could be involved. Another intriguing area of research is the trigger factor inducing autoimmunity in pemphigus patients and the role of T and B cells in this process. This paper will review the data related to the mechanisms of acantholysis between keratinocytes and the role of T cell in this phenomenon.
Similar content being viewed by others
References
Anhalt GJ, Labib RS, Voorhees JJ, Beals TF, Diaz LA (1982) Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med 20:1189–1196
Hertl M, Eming R, Veldman C (2006) T cell control in autoimmune bullous skin disorders. J Clin Invest 116:1159–1166
Pfutze M, Niedermeier A, Hertl M, Eming R (2007) Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus. Eur J Dermatol 17:4–11
Kowalczyk AP, Green KJ, Stanley JR, Hashimoto T, Borgwardt JE, Anderson JE (1995) Pemphigus sera recognize conformationally sensitive epitopes in the amino-terminal region of desmoglein-1. J Invest Dermatol 105:147–152
Koch PJ, Mahoney MG, Ishikawa H, Pulkkinen L, Uitto J, Shultz L, Murphy GF, Whitacker-Menezes D, Stanley JR (1997) Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol 137:1091–1102
Hanakawa Y, Matsuyoshi N, Stanley JR (2002) Expression of desmoglein 1 compensates for genetic loss of desmoglein 3 in keratinocyte adhesion. J Invest Dermatol 119:127
Sekiguchi M, Futei Y, Fujii Y, Iwasaki T, Nishikawa T, Amagai M (2001) Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins. J Immunol 167:5439–5448
Ohata Y, Amagai M, Ishii K, Hashimoto T (2001) Immunoreactivity against intracellular domains of desmogleins in pemphigus. J Dermatol Sci 25:64–71
Calvanico NJ, Robledo MA, Diaz LA (1991) Immunopathology of pemphigus. J Autoimmun 4:3–16
Takeichi M (1991) Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251:1451–1455
Amagai M, Tsunoda K, Suzuki H, Nishifuji K, Koyasu S, Nishikawa T (2000) Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus. J Clin Invest 105:625–631
Berkowitz P, Hu P, Liu Z, Diaz LA, Enghild JJ, Chua MP, Rubenstein DS (2005) Desmosome signalling. J Biol Chem 280:23778
Mahoney MG, Wang ZH, Stanley JR (1999) Explanation for localization of blisters in pemphigus patients. J Invest Dermatol 113:22–26
Calkins CC, Setzer SV, Jennings JM, Summers S, Tsunoda K, Amagai M, Kowalczyk AP (2006) Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies. J Biol Chem 281:7623–7634
Shimizu A, Ishiko A, Ota T, Tsunoda K, Amagai M, Nishikawa T (2004) Ultrastructural changes in mice actively producing antibodies to desmoglein 3 parallel those in patients with pemphigus vulgaris. J Invest Dermatol 122:1145–1148
Frusic-Zlotkin M, Raichenberg D, Wang X, David M, Michel B, Milner Y (2006) Apoptotic mechanism in pemphigus autoimmunoglobulins-induced acantholysis-possible involvement of the EGF receptor. Autoimmunity 39:563–575
Fleming SD, Tsokos GC (2006) Complement, natural antibodies, autoantibodies and tissue injury. Autoimmun Rev 5:89–92
Feliciani C, Toto P, Amerio P, Mohammad PS, Concione G, Amerio P, Shivji G, Wang B, Sauder DN (2000) In vitro and in vivo expression of IL-1 alpha and TNF alpha mRNA in pemphigus vulgaris: IL1 alpha and TNF alpha are involved in acantholysis. J Invest Dermatol 11:71–75
Seko Y, Cole S, Kasprzak W, Shapiro BA, Ragheb JA (2006) The role of cytokine mRNA stability in the pathogenesis of autoimmune disease. Autoimmun Rev 5:299–305
Feliciani C, Toto P, Amerio P, Suzuki H, Shivji G, Wang B, Woodley D, Sauder DN (2000) Immune modulation in pemphigus vulgaris: role for CD28 and IL-10. J Immunol 164:522–526
Caproni M, Giomi B, Cardinali C, Salvatore E, Pestelli E, D’Agata A, Bianche B, Toto P, Feliciani C, Fabbri P (2001) Further support for a role Th2-like cytokines in blister formation of pemphigus. Clin Immunol 98:264–268
Chernyavsky AI, Arredondo J, Kitajima Y, Sato-Nagai M, Grando SA (2007) Desmoglein vs. non-desmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens. J Biol Chem 282:13804–13812
Allen E, Yu QC, Fuchs E (1996) Mice expressing a mutant desmosomal cadherin exhibit abnormalities in desmosomes, proliferation, and epidermal differentiation. J Cell Biol 133:1367–1382
Rickman L, Simrak D, Stevens HP, Hunt DM, King IA, Bryant SP, Eady RA, Leigh IM, Arnemann J, Magee AI, Kelsell DP, Buxton RS (1999) N-terminal deletion in a desmosomal cadherin causes the autosomal dominant skin disease striate palmoplantar keratoderma. Hum Mol Genet 8:971–976
Diaz LA, Arteaga LA, Hilario-Vargas J, Valenzuela JG, Li N, Warren S, Aoki V, Hans-Filho G, Eaton D, dos Santos V, Nutman TB, de Mayolo AA, Qaqish BF, Sampaio SA, Rivitti EA, Cooperative Group on Fogo Selvagem Research (2004) Anti-desmoglein-1 antibodies in onchocerciasis, leishmaniasis and Chagas disease suggest a possible etiological link to Fogo selvagem. J Invest Dermatol 123:1045–1051
Korman NJ, Eyre RW, Zone J, Stanley JR (1991) Demonstration of an adhering-junction molecule (plakoglobin) in the autoantigens of pemphigus foliaceus and pemphigus vulgaris. N Engl J Med 321:631–635
Nguyen VT, Ndoye A, Shultz LD, Pittelkow MR, Grando SA (2000) Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions. J Clin Invest 106:1467–1479
Calvanico NJ, Swartz SJ (1994) A non-desmoglein component of bovine epidermis reactive with pemphigus foliaceus sera. J Autoimmun 7:231–242
Tron F, Gilbert D, Mouquet H, Joly P, Drouot L, Makni S, Masmoudi H, Charron D, Zitouni M, Loiseau P, Ben Ayed M (2005) Genetic factors in pemphigus. J Autoimmun 24:319–328
Loiseau P, Lecleach L, Prost C, Lepage V, Busson M, Bastuji-Garin S, Roujeau JC, Charron D (2000) HLA class II polymorphism contributes to specify desmoglein derived peptides in pemphigus vulgaris and pemphigus foliaceus. J Autoimmun 15:67–73
Gazit E, Loewenthal R (2005) The immunogenetics of pemphigus vulgaris. Autoimmun Rev 4:16–20
Hertl M, Veldman C (2003) T-cellular autoimmunity against desmogleins in pemphigus, an autoantibody-mediated bullous disorder of the skin. Autoimmun Rev 2:278–283
Veldman C, Hohne A, Dieckmann D, Schuler G, Hertl M (2004) Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris. J Immunol 172:6468–6475
Joly P, Mouquet H, Roujeau JC, D’Incan M, Gilbert D, Jacquot S, Gougeon ML, Bedane C, Muller R, Dreno B, Doutre MS, Delaporte E, Pauwels C, Franck N, Caux F, Picard C, Tancrede-Bohin E, Bernard P, Tron F, Hertl M, Musette P (2007) A single cycle of rituximab for the treatment of severe pemphigus. N Engl J Med 357:545–552
Wucherpfennig KW, Yu WB, Bhol K, Monos DS, Argyris E, Karr RW, Ahmed AR, Strominger JL (1995) Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc Natl Acad Sci USA 92:11935–11939
Chang X, Zheng P, Liu Y (2006) FoxP3: a genetic link between immunodeficiency and autoimmune diseases. Autoimmun Rev 5:399–402
Sonderstrup G, Cope AP, Patel S, Congia M, Hain N, Hall FC, Parry SL, Fugger LH, Michie S, McDevitt HO (1999) HLA class II transgenic mice: models of the human CD4+ T-cell immune response. Immunol Rev 172:335–343
Stoll ML, Price KD, Silvin CJ, Jiang F, Gavalchin J (2007) Immunization with peptides derived from the idiotypic region of lupus-associated autoantibodies delays the development of lupus nephritis in the (SWR x NZB)F1 murine model. J Autoimmun 29:30–37
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Veldman, C., Feliciani, C. Pemphigus: A Complex T Cell-dependent Autoimmune Disorder Leading to Acantholysis. Clinic Rev Allerg Immunol 34, 313–320 (2008). https://doi.org/10.1007/s12016-007-8045-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12016-007-8045-y